| SCHEDULE OF BASIC AND DILUTED LOSS PER SHARE POTENTIAL DILUTIVE SECURITIES |
For
the periods ended March 31, 2024 and 2023, the calculations of basic and diluted loss per share are the same because potential dilutive
securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:
SCHEDULE
OF BASIC AND DILUTED LOSS PER SHARE POTENTIAL DILUTIVE SECURITIES
| |
|
March
31, 2024
|
|
|
March
31, 2023
|
|
| |
|
|
|
|
|
|
| Stock options |
|
|
88,275 |
|
|
|
104,325 |
|
| Stock warrants |
|
|
26,724,240 |
|
|
|
847,021 |
|
| Convertible notes payable |
|
|
754,744 |
|
|
|
721,790 |
|
| Total |
|
|
27,567,259 |
|
|
|
1,673,136 |
|
|
For
the years ended September 30, 2023 and 2022, the calculations of basic and diluted loss per share are the same because potential dilutive
securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:
SCHEDULE
OF BASIC AND DILUTED LOSS PER SHARE POTENTIAL DILUTIVE SECURITIES
| |
|
September
30, 2023
|
|
|
September
30, 2022
|
|
| |
|
|
|
|
|
|
| Stock Options |
|
|
102,125 |
|
|
|
98,626 |
|
| Stock Warrants |
|
|
26,284,002 |
|
|
|
806,452 |
|
| Convertible notes payable |
|
|
738,763 |
|
|
|
652,202 |
|
| Unvested restricted common stock |
|
|
- |
|
|
|
250 |
|
| Total |
|
|
27,124,890 |
|
|
|
1,557,530 |
|
|